Dr. Jessica Rose: "[The spike protein] is different by design.
It makes it less 'tasty' to the innate immune system, which makes it harder to clear, which makes it last longer... [Pfizer] knew this when they did their clinical trial that these were accumulating in the liver, the spleen, the ovaries, the brain, the testes, and look at what we're seeing in the adverse event data."